About us Contact Terms of Use Data Sources Publications FAQ
KRAS logo

KRAS

GTPase KRas

Copy number variation

DiseaseSignal Cell linesGain Cell linesAvg. ampLoss Cell linesAvg. lossNo-signal Cell linesAvg. change
cancer 11 8 2.35 3 0.45 136 1.12
NS 8 7 2.76 1 0.48 145 1.09
carcinoma 35 32 3.02 3 0.45 517 1.12
haematopoietic_neoplasm 0 0 0 63 1.04
leukaemia 1 1 4.84 0 83 1.04
lymphoid_neoplasm 1 1 4.84 0 134 1.05
glioma 0 0 0 52 0.97
malignant_melanoma 0 0 0 56 1.10
melanoma 0 0 0 43 1.13
glioblastoma 0 0 0 2 0.97

Cell lines

Cell lineSignalCopy numberAvg. genome ploidyAmplificationDiseaseTissue
22Rv-1 No signal 3 2.04 1.47 cancer, NS, carcinoma prostate
5637 No signal 3 2.99 1.00 cancer, carcinoma bladder, urinary_tract
639-V No signal 2 2.41 0.83 cancer, carcinoma bladder, ureter, urinary_tract
647-V No signal 3 2.50 1.20 cancer, carcinoma bladder, urinary_tract
697 No signal 2 1.98 1.01 haematopoietic_neoplasm, leukaemia, lymphoid_neoplasm blood_bone_marrow, haematopoietic_and_lymphoid_tissue
769-P No signal 2 1.97 1.02 carcinoma kidney
786-0 No signal 4 3.82 1.05 cancer, carcinoma kidney
8-MG-BA No signal 2 2.20 0.91 glioma brain, central_nervous_system
8305C No signal 4 3.09 1.29 carcinoma thyroid
8505C No signal 3 3.00 1.00 carcinoma thyroid